Skip to content
Search AI Powered

Latest Stories

Maryland to Fund Psychedelics Research, Access for Veterans

Maryland to Fund Psychedelics Research, Access for Veterans

The state of Maryland has passed a bill that will allow state funding to provide “cost free” access to psychedelics, such as psilocybin, ketamine, and MDMA for military veterans suffering from traumatic brain injury and post-traumatic stress disorder (PTSD).

Essentially, the measure will establish the Post-Traumatic Stress Disorder and Traumatic Brain Injury Alternative Therapies Fund. The way the bill works is the money from the fund must be allocated specifically for the study of using psychedelics as an alternative therapy for qualifying veterans. 


Instead of signing the bill into law or vetoing it, Gov. Larry Hogan, announced on the 27th of May that he will allow this bill to take effect without his signature.

According to Marijuana Moment, the bill also proposes an annual budget of $1 million for the PTSD fund starting in the fiscal year 2024.

Now that the bill was ​​unanimously approved through both chambers of the state legislature, the Department of Health will have to send a report of initial findings and recommendations to the governor and legislation by December 1, 2022. Two years following that date, they must share any recommendations and findings extrapolated from the PTSD fund studies.

To keep the funding, Maryland’s Department of Health will have to regularly check in with organizations like the Department of Veterans Affairs, Walter Reed National Military Medical Center, Sheppard Pratt hospital, the University of Maryland, and John Hopkins University.

The check ins are to show the effectiveness of using psychedelics as a holistic therapy option for treating veterans with traumatic brain injuries and PTSD.

Maryland Isn’t the Only State Eyeing Reform for Psychedelics

As of right now, Maryland is only one of many states considering new legislation around psychedelics.

States such as Colorado, Connecticut, Oregon, Missouri, Maine, and Utah currently have bills signed or working towards getting signed that would legalize the therapeutic use of psychedelics, like psilocybin.

Pennsylvania, Oklahoma, Hawaii, Washington, and Georgia are putting funding behind research of using psilocybin as holistic medicine.

Then there are states like New Hampshire, Virginia, Rhode Island, and Oklahoma that have passed bills or are in the process of creating bills to decriminalize psychedelics.

Need a little more Bluntness in your life? Subscribe for our newsletter to stay in the loop.

More For You

Magic mushrooms come in more strains than you might realize.
Magic mushrooms come in more strains than you might realize.

Magic Mushrooms: An Overview of Different Psilocybin Strains and Effects

Like cannabis, magic mushrooms exist as strains and species. These terms are used to describe the physical or chemical characteristics of the plants. While they are often used interchangeably, strains and species are not the same. 

Psilocybin mushrooms contain psilocybin, psilocin, and baeocystin. These compounds interact with the serotonin receptors to control biological and neurological processes like sleep, anxiety, cognition, appetite, nausea, learning, memory, and thermoregulation. 

Keep ReadingShow less
Dosage levels can lead to completely different experiences with psilocybin.
Dosage levels can lead to completely different experiences with psilocybin.
Photo by Artur Kornakov on Unsplash

Psilocybin 101: Macrodosing vs. Microdosing

Mental health experts are shifting more attention to the world of psychedelics: specifically psilocybin, a.k.a. “magic mushrooms.” 

Cultures around the world have been utilizing the spiritual fungi for centuries, and as today’s society challenges what so many have been ingrained to view as “wrong” for decades, more people are experimenting with shrooms and exploring the positive effects they seem to have on the human psyche. 

Keep ReadingShow less
Will Insurance Cover Psychedelic-Assisted Therapy?
Will Insurance Cover Psychedelic-Assisted Therapy?

Will My Insurance Cover Psychedelic-Assisted Therapy? 

The American Medical Association (AMA) has taken a significant step forward for psychedelic therapy by approving Current Procedural Technology (CPT) III codes for these treatments. The move has sparked hope among advocates and experts that insurance coverage for psychedelic-assisted therapy is on the horizon. However, this approval is only one piece of the puzzle, and there are several hurdles to overcome before insurance providers will consider reimbursing patients for these treatments.

CPT codes are essential in the healthcare industry as they allow healthcare providers to track and bill for various procedures and services. The newly approved CPT III codes for psychedelic therapies will become effective in January 2024. 

Keep ReadingShow less
Ranking Magic Mushrooms by Potency
Ranking Magic Mushrooms by Potency
Tripsitter

Shroom Showdown: Ranking Magic Mushrooms by Potency

From  Psilocybe azurescens to Psilocybe cubensis   — the potency of magic mushrooms varies greatly.

A single gram of one species is enough to shift reality on its axis — the same amount of another may be barely perceptible.

Keep ReadingShow less
Tripping with your phone? Maybe.
Tripping with your phone? Maybe.

These Apps Could Help You Experience A Trip Without Tripping

Psychedelic exploration is seeing its first renaissance since the mid-century, but while the substances seem to have a largely positive effect on a person’s mental and physical wellbeing, the idea of “tripping” might still sound terrifying to a number of people. 

Thankfully, there’s an app for that – i.e., a number of apps designed to allow people to experience something similar to a psychedelic journey without actually indulging in any psychedelics.  

Keep ReadingShow less